Keith Alan Goldan
Net Worth
Last updated:
What is Keith Alan Goldan net worth?
The estimated net worth of Mr. Keith Alan Goldan is at least $4,385,105 as of 16 Mar 2022. He owns shares worth $1,360,570 as insider, has earned $23,485 from insider trading and has received compensation worth at least $3,001,050 in OptiNose, Inc..
What is the salary of Keith Alan Goldan?
Mr. Keith Alan Goldan salary is $600,210 per year as Chief Financial Officer in OptiNose, Inc..
How old is Keith Alan Goldan?
Mr. Keith Alan Goldan is 54 years old, born in 1971.
What stocks does Keith Alan Goldan currently own?
As insider, Mr. Keith Alan Goldan owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| OptiNose, Inc. (OPTN) | Chief Financial Officer | 141,726 | $9.6 | $1,360,570 |
What does OptiNose, Inc. do?
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.
Keith Alan Goldan insider trading
OptiNose, Inc.
Mr. Keith Alan Goldan has made 5 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he sold 4,617 units of OPTN stock worth $9,742 on 16 Mar 2022.
The largest trade he's ever made was exercising 4,617 units of OPTN stock on 16 Mar 2022. As of 16 Mar 2022 he still owns at least 141,726 units of OPTN stock.
OptiNose key executives
OptiNose, Inc. executives and other stock owners filed with the SEC:
- Dr. Ramy A. Mahmoud M.D., M.P.H. (60) Pres & Chief Operating Officer
- Mr. Keith Alan Goldan (54) Chief Financial Officer
- Mr. Michael F. Marino (49) Chief Legal Officer & Corporation Sec.
- Mr. Peter K. Miller (64) Chief Executive Officer & Director
- Mr. Victor M. Clavelli (52) Chief Commercial Officer